Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BioProgress Gelatin-Free Capsules Address Vegetarian, Ethical Concerns

This article was originally published in The Tan Sheet

Executive Summary

BioProgress Technology International's XGel Film System, the first one-piece soft capsule technology containing a cellulose base instead of gelatin, has been licensed by Peter Black Healthcare, the leading supplier of private label vitamins, minerals and herbal supplements in the U.K.
Advertisement

Related Content

Banner Pharmacaps Extends Portfolio With Non-Animal, Enteric Dosage Forms
Banner Pharmacaps Extends Portfolio With Non-Animal, Enteric Dosage Forms
Banner Pharmacaps Extends Portfolio With Non-Animal, Enteric Dosage Forms
Capitol Hill BSE
Capitol Hill BSE
Capitol Hill BSE
Cautious Approach To Bovine Tissue-Containing Supplements Urged By FDA
Cautious Approach To Bovine Tissue-Containing Supplements Urged By FDA
Cautious Approach To Bovine Tissue-Containing Supplements Urged By FDA

Topics

Advertisement
UsernamePublicRestriction

Register

PS091501

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel